Jiang H
Cancer Manag Res. 2025; 17:219-237.
PMID: 39912095
PMC: 11796448.
DOI: 10.2147/CMAR.S495169.
Anandi L, Garcia J, Ros M, Janska L, Liu J, Carmona-Fontaine C
Life Sci Alliance. 2024; 8(1).
PMID: 39419548
PMC: 11487089.
DOI: 10.26508/lsa.202403053.
Amissah H, Combs S, Shevtsov M
Cells. 2024; 13(13.
PMID: 38994941
PMC: 11240553.
DOI: 10.3390/cells13131087.
Talebian S, Shahnavaz B, Shakiba M, Rassouli F
Heliyon. 2024; 10(10):e31414.
PMID: 38813193
PMC: 11133906.
DOI: 10.1016/j.heliyon.2024.e31414.
Cao K, Yuan W, Hou C, Wang Z, Yu J, Wang T
Cancers (Basel). 2024; 16(3).
PMID: 38339335
PMC: 10854715.
DOI: 10.3390/cancers16030584.
Hypoxia-induced ZEB1 promotes cervical cancer immune evasion by strengthening the CD47-SIRPα axis.
Chen X, Guo C, Wang Z, Yang Y, Pan Y, Liang J
Cell Commun Signal. 2024; 22(1):15.
PMID: 38183060
PMC: 10768116.
DOI: 10.1186/s12964-023-01450-4.
The third dimension of tumor microenvironment-The importance of tumor stroma in 3D cancer models.
Plava J, cehakova M, Kuniakova M, Trnkova L, Cihova M, Bohac M
Exp Biol Med (Maywood). 2023; 248(15):1347-1358.
PMID: 37750028
PMC: 10625342.
DOI: 10.1177/15353702231198050.
Photoacoustic imaging for investigating tumor hypoxia: a strategic assessment.
Nasri D, Manwar R, Kaushik A, Er E, Avanaki K
Theranostics. 2023; 13(10):3346-3367.
PMID: 37351178
PMC: 10283067.
DOI: 10.7150/thno.84253.
VE-Cadherin in Cancer-Associated Angiogenesis: A Deceptive Strategy of Blood Vessel Formation.
Delgado-Bellido D, Oliver F, Vargas Padilla M, Lobo-Selma L, Chacon-Barrado A, Diaz-Martin J
Int J Mol Sci. 2023; 24(11).
PMID: 37298296
PMC: 10253758.
DOI: 10.3390/ijms24119343.
JP1 normalizes tumor vasculature to suppress metastasis and facilitate drug delivery by inhibiting IL-8.
Cui J, Che Z, Zou L, Chen D, Xie Z, Ding K
JCI Insight. 2023; 8(12).
PMID: 37192004
PMC: 10371244.
DOI: 10.1172/jci.insight.161675.
Endogenous myoglobin expression in mouse models of mammary carcinoma reduces hypoxia and metastasis in PyMT mice.
Aboouf M, Armbruster J, Guscetti F, Thiersch M, Boss A, Godecke A
Sci Rep. 2023; 13(1):7530.
PMID: 37161046
PMC: 10170105.
DOI: 10.1038/s41598-023-34614-w.
Novel hypoxia-related gene signature for predicting prognoses that correlate with the tumor immune microenvironment in NSCLC.
Li Z, Cui Y, Zhang S, Xu J, Shao J, Chen H
Front Genet. 2023; 14:1115308.
PMID: 37091782
PMC: 10115983.
DOI: 10.3389/fgene.2023.1115308.
Bacterial-mediated synthesis and characterization of copper oxide nanoparticles with antibacterial, antioxidant, and anticancer potentials.
Talebian S, Shahnavaz B, Nejabat M, Abolhassani Y, Rassouli F
Front Bioeng Biotechnol. 2023; 11:1140010.
PMID: 36949885
PMC: 10025390.
DOI: 10.3389/fbioe.2023.1140010.
Glioblastoma and the search for non-hypothesis driven combination therapeutics in academia.
Johanssen T, McVeigh L, Erridge S, Higgins G, Straehla J, Frame M
Front Oncol. 2023; 12:1075559.
PMID: 36733367
PMC: 9886867.
DOI: 10.3389/fonc.2022.1075559.
Liquid biopsy for monitoring of tumor dormancy and early detection of disease recurrence in solid tumors.
Heidrich I, Deitert B, Werner S, Pantel K
Cancer Metastasis Rev. 2023; 42(1):161-182.
PMID: 36607507
PMC: 10014694.
DOI: 10.1007/s10555-022-10075-x.
Hypoxic activation of PFKFB4 in breast tumor microenvironment shapes metabolic and cellular plasticity to accentuate metastatic competence.
Dai T, Rosario S, Katsuta E, Sawant Dessai A, Paterson E, Novickis A
Cell Rep. 2022; 41(10):111756.
PMID: 36476868
PMC: 9807018.
DOI: 10.1016/j.celrep.2022.111756.
Non-Invasive and Real-Time Monitoring of the Breast Cancer Metastasis Degree via Metabolomics.
Zhu W, Qian W, Liao W, Huang X, Xu J, Qu W
Cancers (Basel). 2022; 14(22).
PMID: 36428687
PMC: 9688400.
DOI: 10.3390/cancers14225589.
Plasticity of cancer invasion and energy metabolism.
Parlani M, Jorgez C, Friedl P
Trends Cell Biol. 2022; 33(5):388-402.
PMID: 36328835
PMC: 10368441.
DOI: 10.1016/j.tcb.2022.09.009.
A narrative review of circulating tumor cells clusters: A key morphology of cancer cells in circulation promote hematogenous metastasis.
Chen Q, Zou J, He Y, Pan Y, Yang G, Zhao H
Front Oncol. 2022; 12:944487.
PMID: 36059616
PMC: 9434215.
DOI: 10.3389/fonc.2022.944487.
Acute vs. chronic vs. intermittent hypoxia in breast Cancer: a review on its application in in vitro research.
Liu Q, Palmgren V, Danen E, Le Devedec S
Mol Biol Rep. 2022; 49(11):10961-10973.
PMID: 36057753
PMC: 9618509.
DOI: 10.1007/s11033-022-07802-6.